IRS1 and breast cancer: Moreover, a dynamic interplay between IGF and ERα in breast cancer cells has been demonstrated, where IGF-1R increase ERα phosphorylation and activity via mTOR/S6K1 and ERα mediates IGF-1R, IRS-1 and IGF ligand expression [28].